The last couple of weeks have been choppy for most of the international stock markets, with UK FTSE 100 swinging between 7140 and 6940 points, US index S&P 500 shuffling between 2815 and 2640 points and India based Nifty 50 index trading between 10600 and 10000 points.
Consequently, in the shorter term, it is not easy to determine which direction world indices may go, but most of them have broken below their uptrend channels in the medium term charts and are waiting for the next course of action which will eventually be first reflected in the short term chart.
To bring down uncertainty in the market, companies like FMCG, Pharma and Logistics help tide over market volatility. They are considered defensives, as traders and investors use them as a hedge to safeguard their portfolios from major downside. But company internals are equally important. If a company is not doing very well from inside, it may turn out to be a poor investment irrespective of market direction.
We look at three international stocks today, one FMCG and one Pharma and Health Care.
AstraZeneca PLC ADR (NYSE:AZN) Close: 41.49
Headquartered in UK, listed on both US and UK stock exchanges, the Anglo–Swedish multinational pharmaceutical company ASTRAZENECA PLC is inside a rising trend channel in the medium term. This signals increasing optimism among investors and that the company's prospects continue to be promising in the coming future.
The stock price has given a new buy signal from a rectangle formation and a break up through the resistance at 40.39 dollars. Further rise to 43.45 dollars or more is signaled. The stock has support at 39.70 and 37 dollars respectively.
Investtech's outlook (one to six months): Buy
Procter & Gamble Company (NYSE:PG) Close: 93.47
Procter & Gamble has broken up through the ceiling of the rising trend channel in the medium term. According to Investtech's research analysis done in four Scandinavian markets, average price development for shares with breakouts from the rising medium-term trend has yielded a weighted average of 3.3 % excess return compared to index on an annual basis. It indicates a strong further price development in that stock.
This recent price move of this world renowned FMCG company has been supported by high volume, which suggests that buyers have been aggressive while sellers were passive. Also the momentum indicator RSI is above 70and is at a multi-month high. It indicates rising optimism among investors and further rise in stock price.
Procter & Gamble Company may have some resistance around 94.40 dollars, which is its earlier top. A close above that level will be a new buy signal and the stock would continue to rise. There is support between 92.40 and 86.00 dollars.
Investtech's outlook (one to six months): Buy
The analyses are based on closing price as per November 13, 2018.
Disclaimer: All analyses used herein are subjective opinions of the author and should not be considered as specific investment advice. Investors/Traders must consider all relevant risk factors including their own personal financial situation before trading.